Dublin - The global market for achromatopsia is projected to witness significant growth, with estimations indicating an increase from USD 121.99 million in 2026 to USD 191.22 million by 2032, representing a compound annual growth rate of 7.58%. This growth is attributed to advancements in genetic characterization, diagnostics, and treatment options within the field of achromatopsia. The market landscape for achromatopsia is outlined in a comprehensive research report available on ResearchAndMarkets.com.